UBS Group’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $482K | Buy |
|
|||||
|
2025
Q1 | $234K | Sell |
|
|||||
|
2024
Q4 | $637K | Buy |
|
|||||
|
2024
Q3 | $136K | Buy |
|
|||||
|
2024
Q2 | $116K | Sell |
|
|||||
|
2024
Q1 | $298K | Buy |
|
|||||
|
2023
Q4 | $278K | Sell |
|
|||||
|
2023
Q3 | $418K | Sell |
|
|||||
|
2023
Q2 | $1.45M | Buy |
|
|||||
|
2023
Q1 | $60.7K | Buy |
|
|||||
|
2022
Q4 | $22.5K | Buy |
|